Clinical Trial Update: Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China [Phase 4]

View source ↗

Summary

Phase IV study evaluating the safety and efficacy of everolimus in adults with progressive pancreatic neuroendocrine tumors in China has completed, with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Neuroendocrine Tumor

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Pancreatic Neuroendocrine Tumors | Phase 4 | Status: COMPLETED | Results posted: 2025-02-10